SeQuent® Please OTW

Description

SeQuent® Please OTW features an optimized and clinically proven drug-coating technology which facilitates the safe and effective treatment of patients with peripheral arterial disease (PAD) in above and below the knee indications. ^{[1, 2]}

Controlled and effective drug dosage of Paclitaxel

• Drug Dosage 3μg/mm2
• Effective reduction of TLR compared to uncoated balloons
• Homogeneous coating even in the balloon folds exceeding distal and proximal markers

Resveratrol: A hydrophilic excipient

• Naturally occurring, plant-based substance
• Acts as hydrophilic spacer and makes the Paclitaxel bioavailable
• Enables controlled drug transfer into vessel wall

Mechanically resistant coating ^[3]

• Low drug loss in simulated use (<2 %)
• High available drug dose at inflation
• Designed for technical success
• Kink resistant shaft
• Low crossing profile